Sickle Cell Test
MeriScreen by Meril
MERISCREEN Sickle Cell Test delivers rapid, accurate sickle cell disease screening with >99% sensitivity and specificity using sandwich immunoassay technology. This point-of-care diagnostic device requires only 5µL blood sample and provides qualitative results in 10 minutes. Compatible with both finger prick capillary and venous whole blood specimens, making it ideal for emergency departments, outpatient clinics, and primary healthcare facilities across Telangana.
Product overview
MERISCREEN Sickle Cell Test delivers rapid, accurate sickle cell disease screening with >99% sensitivity and specificity using sandwich immunoassay technology. This point-of-care diagnostic device requires only 5µL blood sample and provides qualitative results in 10 minutes. Compatible with both finger prick capillary and venous whole blood specimens, making it ideal for emergency departments, outpatient clinics, and primary healthcare facilities across Telangana.
In-vitro immunochromatographic assay for qualitative detection of Hemoglobin A and S variants. Suitable for neonatal/newborn screening. Lateral flow immunoassay. Finger prick, heel prick, or venous whole blood.
Technical specifications
| test time | 10 minutes |
| test type | Sandwich immunoassay |
| sample volume | 5µL blood sample |
| sensitivity | >99% |
| specificity | >99% |
| detection method | Qualitative |
| specimen types | Finger prick capillary and/or venous whole blood |
Surgical Decision Engine
Cross-sell intelligence powered by product knowledge graph